| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/28/2002 | CA2340455A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 09/26/2002 | WO2002075507A2 Anti-bacterial vaccine compositions |
| 09/26/2002 | WO2002075317A2 Screening for drugs against disorders associated with schizophrenia |
| 09/26/2002 | WO2002075314A2 Detection and treatment of prostate cancer |
| 09/26/2002 | WO2002075304A1 Method of examining allergic disease |
| 09/26/2002 | WO2002075273A2 Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor |
| 09/26/2002 | WO2002074986A2 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 09/26/2002 | WO2002074981A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 09/26/2002 | WO2002074980A2 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 09/26/2002 | WO2002074977A2 Sugar and lipid metabolism regulators in plants |
| 09/26/2002 | WO2002074976A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 09/26/2002 | WO2002074973A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 09/26/2002 | WO2002074967A1 Gene-targeted animal model of apolipoprotein e4 domain interaction and uses thereof |
| 09/26/2002 | WO2002074963A1 Dengue viruses that are replication defective in mosquitos for use as vaccines |
| 09/26/2002 | WO2002074961A1 Novel nucleic acids and polypeptides |
| 09/26/2002 | WO2002074960A2 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof |
| 09/26/2002 | WO2002074959A2 Human leucine-rich repeat containing protein expressed predominately in nervous system tissues, hlrrns1 |
| 09/26/2002 | WO2002074958A1 Yeast transformed with cdna of deer velvet antler for the production of efficient pharmacological ingredients and the preparation of the transformed yeast |
| 09/26/2002 | WO2002074957A2 Stress-responsive activator of p300 (strap) protein |
| 09/26/2002 | WO2002074956A2 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 09/26/2002 | WO2002074953A2 Gene library and a method for producing the same |
| 09/26/2002 | WO2002074950A1 Method of analyzing intermolecular interaction |
| 09/26/2002 | WO2002074945A1 Method for cleaving human growth hormone gh |
| 09/26/2002 | WO2002074941A1 Reporter virus comprising heterologous envelope proteins |
| 09/26/2002 | WO2002074931A2 Inhibitors and disassemblers of fibrillogenesis |
| 09/26/2002 | WO2002074928A2 Fusion peptides isolatable by phase transition |
| 09/26/2002 | WO2002074923A2 Targets and screens for agents useful in controlling parasitic nematodes |
| 09/26/2002 | WO2002074921A2 Methods for isolating proteins expressed by dendritic cells |
| 09/26/2002 | WO2002074919A2 Protein-protein interactions |
| 09/26/2002 | WO2002074915A2 Real cloning |
| 09/26/2002 | WO2002074914A2 Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts |
| 09/26/2002 | WO2002074913A2 Nucleic acid-associated proteins |
| 09/26/2002 | WO2002074909A2 Cell cycle nucleic acids, polypeptides and uses thereof |
| 09/26/2002 | WO2002074908A2 Methods and reagents for regulating apoptosis |
| 09/26/2002 | WO2002074906A2 Lp mammalian proteins; related reagents |
| 09/26/2002 | WO2002074905A2 Leptin induced genes |
| 09/26/2002 | WO2002074904A2 Rearranged squamous cell carcinoma antigen genes ii |
| 09/26/2002 | WO2002074903A2 Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
| 09/26/2002 | WO2002074811A1 Regulation of human carboxypeptidase inhibitor-like protein |
| 09/26/2002 | WO2002074810A2 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 09/26/2002 | WO2002074809A2 Zinc-sensing receptor and methods of treatment of disorders associated herewith |
| 09/26/2002 | WO2002074808A2 Modified insulin with reduced immunogenicity |
| 09/26/2002 | WO2002074807A2 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 09/26/2002 | WO2002074806A2 New interferon beta-like molecules |
| 09/26/2002 | WO2002074805A1 Soluble rage protein |
| 09/26/2002 | WO2002074804A2 Use of binding domains of presenilins and transmembrane proteins for drug screening |
| 09/26/2002 | WO2002074803A2 Regulation of human icos v protein |
| 09/26/2002 | WO2002074802A2 Recombinant p. vivax merozoite protein-1 p42 vaccine |
| 09/26/2002 | WO2002074800A1 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening |
| 09/26/2002 | WO2002074799A2 Pepsin-sensitive modified bacillus thuringiensis insecticidal toxin |
| 09/26/2002 | WO2002074798A2 The genome of a bifidobacterium |
| 09/26/2002 | WO2002074797A2 Protein having multiple antigen/epitope sequences and being immobilized for the diagnosis of hiv infections |
| 09/26/2002 | WO2002074796A2 Histidine phosphatase interacting protein with 240kd |
| 09/26/2002 | WO2002074795A2 Oligomeric complexes of chimeric proteins with enhanced immunogenic potential |
| 09/26/2002 | WO2002074794A2 Compositions useful in gene therapy |
| 09/26/2002 | WO2002074793A2 Novel peptides for the diagnosis of schizophrenia |
| 09/26/2002 | WO2002074791A1 Method for purification of molecules using unbranched terminal alkyldiols |
| 09/26/2002 | WO2002074788A2 TRP2 ISOFORM TRP2-6b CONTAINING HLA-A2-RESTRICTED EPITOPES |
| 09/26/2002 | WO2002074787A2 Compositions and methods for identifying, characterizing, optimizing and using ligands to transcytotic molecules |
| 09/26/2002 | WO2002074783A2 Modified interferon beta with reduced immunogenicity |
| 09/26/2002 | WO2002074344A2 Peg-conjugates of hgt-nk4 |
| 09/26/2002 | WO2002074331A2 Mutated mhc molecules for use in immune suppression |
| 09/26/2002 | WO2002074327A2 Compositions and methods for treating gonadotrophin related illnesses |
| 09/26/2002 | WO2002074326A2 Urocortin-iii and uses thereof |
| 09/26/2002 | WO2002074249A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/26/2002 | WO2002074243A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 09/26/2002 | WO2002074239A2 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/26/2002 | WO2002074237A2 Compositions and methods for the therapy and diagnosis of kidney cancer |
| 09/26/2002 | WO2002074234A2 Method and composition for treatment of skeletal dysplasias |
| 09/26/2002 | WO2002074193A2 METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN ss4 (Tss4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES |
| 09/26/2002 | WO2002074156A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 09/26/2002 | WO2002074079A2 Polynucleotide encoding a gene conferring resistance to bacillus thuringiensis toxins |
| 09/26/2002 | WO2002074071A2 Transgenic animal model of ige-mediated allergic responses |
| 09/26/2002 | WO2002074048A2 P-glycoproteins and uses thereof |
| 09/26/2002 | WO2002074045A2 Production of pancreatic islet cells and delivery of insulin |
| 09/26/2002 | WO2002062999A8 Proteins and nucleic acids encoding same |
| 09/26/2002 | WO2002062957A3 Ter sites and ter binding proteins |
| 09/26/2002 | WO2002062374A3 Muc1 isolation from bovine milk and whey |
| 09/26/2002 | WO2002058638A3 Serpin drugs for treatment of hiv infection and method of use thereof |
| 09/26/2002 | WO2002057406A3 Dna sequencing of abc transporter or multi drug resistant protein for better environment stress tolerant crops |
| 09/26/2002 | WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/26/2002 | WO2002045492A8 Transgenic mice containing polycystin-related gene disruptions |
| 09/26/2002 | WO2002040537A3 Analogues and derivatives of gastrin releasing peptide (grp) |
| 09/26/2002 | WO2002040501A3 Membrane scaffold proteins |
| 09/26/2002 | WO2002038609A3 Apolipoprotein conjugates |
| 09/26/2002 | WO2002036167A8 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 09/26/2002 | WO2002032945A3 Haemophilus influenzae basb206 gene and protein |
| 09/26/2002 | WO2002032397A8 Electroprocessing in drug delivery and cell encapsulation |
| 09/26/2002 | WO2002031155A3 Gene cluster for ramoplanin biosynthesis |
| 09/26/2002 | WO2002030959A3 Peptides derived from smac (diablo) and methods of use therefor |
| 09/26/2002 | WO2002030421A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 09/26/2002 | WO2002029084A3 Industrial-scale serum-free production of recombinant factor vii in mammalian cells |
| 09/26/2002 | WO2002022685A3 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 09/26/2002 | WO2002022656A3 An hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof |
| 09/26/2002 | WO2002020568A3 Mutant peptides derived from bad and their use to identify substances which bind to a member of the bcl-2 family of proteins |
| 09/26/2002 | WO2002019813A3 Method of obtaining a non-human mammal susceptible to adenovirus-mediated gene delivery |
| 09/26/2002 | WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 09/26/2002 | WO2002016396A9 Mammalian rh type b glycoprotein ion transporter |
| 09/26/2002 | WO2002015675A8 Genes for modifying plant traits iv |
| 09/26/2002 | WO2002004519A3 Murine cytokine receptor |